326 related articles for article (PubMed ID: 9751632)
41. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
Jiang YP; Shen Y; Sun N; Wang H
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
[TBL] [Abstract][Full Text] [Related]
42. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
43. [WT1 (Wilms Tumor 1). Tumor suppressor gene].
Bull Cancer; 1998 Dec; 85(12):983-4. PubMed ID: 9988551
[No Abstract] [Full Text] [Related]
44. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
45. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
Baudry D; Faussillon M; Cabanis MO; Rigolet M; Zucker JM; Patte C; Sarnacki S; Boccon-Gibod L; Junien C; Jeanpierre C
Oncogene; 2002 Aug; 21(36):5566-73. PubMed ID: 12165855
[TBL] [Abstract][Full Text] [Related]
46. Analysis of possible WT1 RNA processing in primary Wilms tumors.
Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
[TBL] [Abstract][Full Text] [Related]
47. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
Bruening W; Bardeesy N; Silverman BL; Cohn RA; Machin GA; Aronson AJ; Housman D; Pelletier J
Nat Genet; 1992 May; 1(2):144-8. PubMed ID: 1302008
[TBL] [Abstract][Full Text] [Related]
48. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
49. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
50. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.
Yeger H; Cullinane C; Flenniken A; Chilton-MacNeil S; Campbell C; Huang A; Bonetta L; Coppes MJ; Thorner P; Williams BR
Cell Growth Differ; 1992 Dec; 3(12):855-64. PubMed ID: 1335280
[TBL] [Abstract][Full Text] [Related]
51. Novel frame shift mutations ('A' deletion) observed in exon 9 of Wilms' tumor (WT1) gene in a patient reported with glomerulosclerosis.
Pasupuleti SK; Katari V; Lokanathan S; Uppu VP; Thummaginjala SS; Akkamgari RP; Ayapati T; Kottu R; Potukuchi VG
Gene; 2014 Aug; 546(1):63-7. PubMed ID: 24853201
[TBL] [Abstract][Full Text] [Related]
52. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
Mrowka C; Schedl A
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
[TBL] [Abstract][Full Text] [Related]
53. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
[TBL] [Abstract][Full Text] [Related]
54. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
55. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
56. [Wilms' tumors and malformation complexes].
Hata J; Fukuzawa R; Takata A; Kikuchi H
Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
[TBL] [Abstract][Full Text] [Related]
57. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.
Rong Y; Cheng L; Ning H; Zou J; Zhang Y; Xu F; Liu L; Chang Z; Fu XY
Cancer Res; 2006 Aug; 66(16):8049-57. PubMed ID: 16912181
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
Udtha M; Lee SJ; Alam R; Coombes K; Huff V
Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
[TBL] [Abstract][Full Text] [Related]
59. [Nephroblastoma (Wilms' tumor): cytogenetic and molecular biology principles].
Strohmeyer T
Klin Padiatr; 1993; 205(3):135-9. PubMed ID: 8394474
[TBL] [Abstract][Full Text] [Related]
60. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line.
McMaster ML; Gessler M; Stanbridge EJ; Weissman BE
Cell Growth Differ; 1995 Dec; 6(12):1609-17. PubMed ID: 9019166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]